Marker Therapeutics, Inc.
MRKR
Revenue
0.00
0.000.00%
3 Months ChangeAssets
11.68M
▼-2.42M▼-17.15%
3 Months ChangeLiabilities
1.97M
▼-331.42k▼-14.39%
3 Months ChangeFree Cash Flow
-4.20M
▼-95.60k▼-2.33%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 8-K
ID: 0001104659-24-089704
2024-08-14
Form 10-Q
ID: 0001410578-24-001454
2024-08-12
Form 8-K
ID: 0001104659-24-088054
2024-06-12
Form 8-K
ID: 0001104659-24-070830
2024-05-15
Form 8-K
ID: 0001104659-24-062001
2024-05-15
Form 10-Q
ID: 0001410578-24-000865
2024-04-08
Form 8-K
ID: 0001104659-24-044496
2024-03-26
Form 8-K
ID: 0001104659-24-038533
2024-03-01
Form 8-K
ID: 0001104659-24-029638
2024-02-26
Form 8-K
ID: 0001104659-24-027293